Rinaldi, A. (2018). Setbacks and promises for drugs against Alzheimer's disease: As pharmaceutical companies are retreating from drug development for Alzheimer's, new approaches are being tested in academia and biotech companies. EMBO Rep.
Dyfyniad Arddull ChicagoRinaldi, Andrea. "Setbacks and Promises for Drugs against Alzheimer's Disease: As Pharmaceutical Companies Are Retreating From Drug Development for Alzheimer's, New Approaches Are Being Tested in Academia and Biotech Companies." EMBO Rep 2018.
Dyfyniad MLARinaldi, Andrea. "Setbacks and Promises for Drugs against Alzheimer's Disease: As Pharmaceutical Companies Are Retreating From Drug Development for Alzheimer's, New Approaches Are Being Tested in Academia and Biotech Companies." EMBO Rep 2018.